Cargando…

Immune characterization of a xenogeneic human lung cross-circulation support system

Improved approaches to expanding the pool of donor lungs suitable for transplantation are critically needed for the growing population with end-stage lung disease. Cross-circulation (XC) of whole blood between swine and explanted human lungs has previously been reported to enable the extracorporeal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wei K., Stier, Matthew T., Stokes, John W., Ukita, Rei, Patel, Yatrik J., Cortelli, Michael, Landstreet, Stuart R., Talackine, Jennifer R., Cardwell, Nancy L., Simonds, Elizabeth M., Mentz, Meredith, Lowe, Cindy, Benson, Clayne, Demarest, Caitlin T., Alexopoulos, Sophoclis P., Shaver, Ciara M., Bacchetta, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065447/
https://www.ncbi.nlm.nih.gov/pubmed/37000867
http://dx.doi.org/10.1126/sciadv.ade7647
Descripción
Sumario:Improved approaches to expanding the pool of donor lungs suitable for transplantation are critically needed for the growing population with end-stage lung disease. Cross-circulation (XC) of whole blood between swine and explanted human lungs has previously been reported to enable the extracorporeal recovery of donor lungs that declined for transplantation due to acute, reversible injuries. However, immunologic interactions of this xenogeneic platform have not been characterized, thus limiting potential translational applications. Using flow cytometry and immunohistochemistry, we demonstrate that porcine immune cell and immunoglobulin infiltration occurs in this xenogeneic XC system, in the context of calcineurin-based immunosuppression and complement depletion. Despite this, xenogeneic XC supported the viability, tissue integrity, and physiologic improvement of human donor lungs over 24 hours of xeno-support. These findings provide targets for future immunomodulatory strategies to minimize immunologic interactions on this organ support biotechnology.